A Stability Indicating RP-HPLC Method for Simultaneous Estimation of Acebrophylline, Montelukast, and Fexofenadine in Bulk and Pharmaceutical Dosage Forms
1★, 1, 1★ Corresponding author
- 1Institute of Pharmaceutical Technology, Sri Padmavathi Mahila Visvavidyalayam, Tirupati, Andhra Pradesh, INDIA.
CORRESPONDENCE
Sreedevi Adikay
Institute of Pharmaceutical Technology, Sri Padmavathi Mahila Visvavidyalayam, Tirupati, Andhra Pradesh, INDIA.
Received: 09-11-2022; Revised: 26-11-2022; Accepted: 21-12-2022.
Volume 13, Issue 2 · pp. 306-312 · 2023 · DOI: 10.5530/ijpi.13.2.040
ABSTRACT
Introduction: The goal of the current work is to create an RP-HPLC method for the quantitative analysis of Acebrophylline, Montelukast, and Fexofenadine in Pharmaceutical dosage form.Materials and Methods: Chromatographic separation of Acebrophylline, Montelukast and Fexofenadine was executed on Waters Alliance-e 2695, by using Hyper clone 5µ BDS C 8 132A (252 x 4.6mm) column and the mobile phase consisting of Methanol: Ammonium formate adjusted to pH-6 and ortho phosphoric acid (72:132). The flow rate: .2 mL/min, Column temperature: 25°C and detection wavelength 268nm utilizing a photodiode array detector. Results and Discussion: According to ICH criteria, the new approach was validated, and forced degradation tests are also carried out. The procedure is effective for the precise identification and quantification of the three medicines in relation to all of the revealed validation factors. The technique also shows to be suitable for identifying chemical degradation.Conclusion: Therefore, the approach created can be utilized for quality control and routine laboratory analysis of these particular medications.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Adikay, S., Bhavanasi, M., & Kaveripakam, S. S. (2023). A Stability Indicating RP-HPLC Method for Simultaneous Estimation of Acebrophylline, Montelukast, and Fexofenadine in Bulk and Pharmaceutical Dosage Forms. International Journal of Pharmaceutical Investigation, 13(2), 306-312. https://doi.org/10.5530/ijpi.13.2.040
Copyright and licence
© 2023 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0
